MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/130/0.1/20.06.25 Stock

Warrant

DE000MB8GSG1

Real-time Bid/Ask 04:30:01 2024-06-03 EDT
0.23 EUR / 0.27 EUR +4.17% Intraday chart for MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/130/0.1/20.06.25
1 month+35.59%
3 months+4.80%
Date Price Change
24-05-31 0.24 -11.11%
24-05-30 0.27 0.00%
24-05-29 0.27 +33.00%
24-05-28 0.203 +0.50%
24-05-27 0.202 +10.38%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 02:59 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying EDWARDS LIFESCIENCES CORPORATION
Issuer Morgan Stanley
WKN MB8GSG
ISINDE000MB8GSG1
Date issued 2023-07-07
Strike 130 $
Maturity 2025-06-20 (383 Days)
Parity 10 : 1
Emission price 0.55
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.7
Lowest since issue 0.134
Delta0x
Omega 0.000000
Premium0x
Gearing51.45x
Moneyness 1.072
Difference Strike 43.11 $
Difference Strike %+33.16%
Spread 0.04
Spread %14.81%
Intrinsic value 0.8666
Present value -0.616596

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Edwards Lifesciences Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89 USD
Average target price
96.55 USD
Spread / Average Target
+11.12%
Consensus